Release Date: 27/09/11 13:43 Summary: Full Year Statutory Accounts Price Sensitive: No Download Document 1.15MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%